Evidence map›Paper›PMID 38114494›Full record

Trial reportTranslational psychiatry2023

Generalization of beneficial exposure effects to untreated stimuli from another fear category.

Iris Kodzaga, Ekrem Dere, Armin Zlomuzica

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Bypassing as a non-confrontational influence strategy.Current opinion in psychology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Iris KodzagaDepartment of Behavioral and Clinical Neuroscience, Ruhr-University Bochum (RUB), D-44787, Bochum, Germany.ORCID 0000-0003-1708-985X
Ekrem DereDepartment of Behavioral and Clinical Neuroscience, Ruhr-University Bochum (RUB), D-44787, Bochum, Germany.
Armin ZlomuzicaDepartment of Behavioral and Clinical Neuroscience, Ruhr-University Bochum (RUB), D-44787, Bochum, Germany. armin.zlomuzica@rub.de.ORCID 0000-0003-0594-4281

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) ZL 59/4-1Deutsche Forschungsgemeinschaft (German Research Foundation) ZL 59/ 5-1
6 · The paper itself

Abstract

Previous research has shown that fear associated with one stimulus often spreads to other stimuli with similar perceptual features as well as across different stimulus categories. Exposure is considered as the most effective intervention to attenuate exaggerated fear. The extent to which exposure treatment effects can generalize to fears not targeted during treatment remains elusive. Previous studies on possible generalization of beneficial effects of exposure used stimuli sharing the same stimulus category and/or stimuli having high perceptual similarity. The current study examined whether exposure treatment generalization can be achieved for untreated stimuli which do not share any perceptual resemblance and belong to a different fear category. An analogue sample of fifty participants with fear of spiders (animal-related fears) and heights (natural environment-related fears) was tested. Participants have been randomly assigned to either an exposure treatment (n = 24) or a control condition (n = 26). Exposure treatment was designed to only target participants' fear of spiders, leaving their fear of heights untreated. Results demonstrated that the effects of exposure treatment generalized to fear of heights, as indicated by a reduction in behavioral avoidance, as well as self-reported acrophobia symptoms. The present study confutes the assumption that generalization of exposure effects to untreated fears is based on perceptual similarity. Clearly, further research is required to determine the decisive factors, in order to expand the generalization effect permanently to any given type of fear.

Indexed as

Phobic DisordersSpidersAnimalsFearHumans

Identifiers

PMID38114494
PMCPMC10730830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.